Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

More documents

Recommendations

Info

Chapter 5 Do patients with chronic patellar tendinopathy have an altered somatosensory profile? – A Quantitative Sensory Testing (QST) study C. P. van Wilgen, K.H. Konopka, D. Keizer, J. Zwerver, R. Dekker accepted in Scandinavian Journal of Medicine and Science in Sports
5. QST in patients with tendinopathy 0 Abstract The prevalence of tendinopathies in sports is high. The aetiology and pain mechanisms of tendinopathies are not completely understood. Currently, little is known whether, or to which degree, somatosensory changes within the nervous system may contribute to the pain in tendinopathies. We conducted a patient controlled study in which we used the standardized QST protocol developed by the German Research Network on Neuropathic Pain. This protocol consists of 7 different tests that measures 13 somatosensory parameters and can be seen as the gold standard to measure somatosensory function. Twelve athletes with clinically diagnosed chronic patellar tendinopathy (PT) with a mean duration of symptoms of 30 months (range 6 - 120) and 20 control athletes were included in the study. In two of the thirteen QST parameters namely mechanical pain threshold (p
Page 2:
Quantitative Sensory Testing (QST)
Page 5 and 6:
Promotores: Prof. dr. M.M.R.F. Stru
Page 7 and 8:
Paranimfen Marten Harbers Aribert B
Page 9 and 10:
Contents 3.3.4. Sensory changes at
Page 11:
0 Contents Chapter 5 Do patients wi
Page 14:
Chapter 1 General introduction
Page 17 and 18:
1. General introduction stimuli. C-
Page 19 and 20:
1. General introduction Patients re
Page 21 and 22:
1. General introduction 0 drugs (NS
Page 23 and 24:
1. General introduction Table 1-2:
Page 26 and 27:
Chapter 2 Bilateral sensory abnorma
Page 28 and 29:
2. Bilateral abnormalities in neuro
Page 30 and 31: 2. Bilateral abnormalities in neuro
Page 46: 2. Bilateral abnormalities in neuro
Page 49 and 50: 3. Somatosensory function and neuro
Page 51 and 52: 0 3. Somatosensory function and neu
Page 67 and 68: 4. QST and neuropathic pain mechani
Page 79: 4. QST and neuropathic pain mechani
Page 83 and 84: 5. QST in patients with tendinopath
Page 94 and 95: Chapter 6 General discussion and Su
Page 96 and 97: 6. General discussion and Summary s
Page 98 and 99: 6. General discussion and Summary s
Page 100 and 101: 6. General discussion and Summary T
Page 102 and 103: 6. General discussion and Summary Q
Page 104 and 105: 6. General discussion and Summary S
Page 106 and 107: References Abate M, Silbernagel KG,
Page 108 and 109: de la Llave-Rincon AI, Fernandez-de
Page 110 and 111: Kehlet H, Jensen TS, Woolf CJ. 2006
Page 112 and 113: Robinson JM, Cook JL, Purdam C, Vis
Page 114 and 115: Visentini PJ, Khan KM, Cook JL, Kis
Page 116 and 117: Nederlandse samenvatting Met de ont
Page 118 and 119: Acknowledgement To produce a work s
show all

Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

Create successful ePaper yourself

Delete template?

Save as template?